BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 7740052)

  • 1. Crucial role of D1 dopamine receptors in mediating the antidepressant effect of imipramine.
    Gambarana C; Ghiglieri O; Tagliamonte A; D'Alessandro N; de Montis MG
    Pharmacol Biochem Behav; 1995 Feb; 50(2):147-51. PubMed ID: 7740052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Possible role of dopamine D1 receptor in the behavioural supersensitivity to dopamine agonists induced by chronic treatment with antidepressants.
    Serra G; Collu M; D'Aquila PS; De Montis GM; Gessa GL
    Brain Res; 1990 Sep; 527(2):234-43. PubMed ID: 1979237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repeated treatment with imipramine, fluvoxamine and tranylcypromine decreases the number of escape failures by activating dopaminergic systems in a rat learned helplessness test.
    Takamori K; Yoshida S; Okuyama S
    Life Sci; 2001 Sep; 69(16):1919-26. PubMed ID: 11693272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density.
    LaHoste GJ; Marshall JF
    Synapse; 1992 Sep; 12(1):14-26. PubMed ID: 1357762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. D1 and D2 dopamine receptors stimulate hypothalamo-pituitary-adrenal activity in rats.
    Borowsky B; Kuhn CM
    Neuropharmacology; 1992 Jul; 31(7):671-8. PubMed ID: 1328919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of both dopamine D1 and D2 receptors necessary for amelioration of conditioned fear stress.
    Kamei H; Kameyama T; Nabeshima T
    Eur J Pharmacol; 1995 Feb; 273(3):229-33. PubMed ID: 7737329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repeated stimulation of D1 dopamine receptors causes time-dependent alterations in the sensitivity of both D1 and D2 dopamine receptors within the rat striatum.
    Hu XT; Brooderson RJ; White FJ
    Neuroscience; 1992 Sep; 50(1):137-47. PubMed ID: 1357592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antidepressant-like effect of selective dopamine D1 receptor agonists in the behavioural despair animal model of depression.
    D'Aquila PS; Collu M; Pani L; Gessa GL; Serra G
    Eur J Pharmacol; 1994 Sep; 262(1-2):107-11. PubMed ID: 7813561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dizocilpine antagonizes the effect of chronic imipramine on learned helplessness in rats.
    Meloni D; Gambarana C; De Montis MG; Dal Prá P; Taddei I; Tagliamonte A
    Pharmacol Biochem Behav; 1993 Oct; 46(2):423-6. PubMed ID: 7903459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of repeated treatment with imipramine, (+)- and (-)-oxaprotiline on behavioural effects of dopamine D-1 and D-2 agonists.
    Maj J; Papp M; Skuza G; Bigajska K; Zazula M
    J Neural Transm; 1989; 76(1):29-38. PubMed ID: 2565359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repeated administration of fluoxetine, desipramine and tranylcypromine increases dopamine D2-like but not D1-like receptor function in the rat.
    Ainsworth K; Smith SE; Sharp T
    J Psychopharmacol; 1998; 12(3):252-7. PubMed ID: 10958251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine D1 and D2 effects on fetal mouthing responses to milk.
    Smotherman WP; Robinson SR
    Physiol Behav; 1995 Jan; 57(1):15-9. PubMed ID: 7878109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of uncoupling between D1- and D2-mediated motor behavior in rats depleted of dopamine as neonates.
    Byrnes EM; Bruno JP
    Dev Psychobiol; 1994 Sep; 27(6):409-24. PubMed ID: 8001729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polydipsia and dopamine: behavioral effects of dopamine D1 and D2 receptor agonists and antagonists.
    Mittleman G; Rosner AL; Schaub CL
    J Pharmacol Exp Ther; 1994 Nov; 271(2):638-50. PubMed ID: 7965779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fetal behavior and the dopamine system: activity effects of D1 and D2 receptor manipulations.
    Moody CA; Robinson SR; Spear LP; Smotherman WP
    Pharmacol Biochem Behav; 1993 Apr; 44(4):843-50. PubMed ID: 8097042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of chronic treatment with selective agonists on the subtypes of dopamine receptors.
    Subramaniam S; Lucki I; McGonigle P
    Brain Res; 1992 Feb; 571(2):313-22. PubMed ID: 1351781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of D1, but not D2 receptors potentiates dizocilpine-mediated disruption of prepulse inhibition of the startle.
    Bortolato M; Aru GN; Fà M; Frau R; Orrù M; Salis P; Casti A; Luckey GC; Mereu G; Gessa GL
    Neuropsychopharmacology; 2005 Mar; 30(3):561-74. PubMed ID: 15328529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug discrimination in methamphetamine-trained monkeys: agonist and antagonist effects of dopaminergic drugs.
    Tidey JW; Bergman J
    J Pharmacol Exp Ther; 1998 Jun; 285(3):1163-74. PubMed ID: 9618419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulation of dopamine D-2 but not D-1 receptors reduces immobility time of rats in the forced swimming test: implication for antidepressant activity.
    Borsini F; Lecci A; Mancinelli A; D'Aranno V; Meli A
    Eur J Pharmacol; 1988 Apr; 148(3):301-7. PubMed ID: 2968270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of morphine on memory consolidation in mice involve both D1 and D2 dopamine receptors.
    Castellano C; Cestari V; Cabib S; Puglisi-Allegra S
    Behav Neural Biol; 1994 Mar; 61(2):156-61. PubMed ID: 7911301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.